Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients and developer of targeted oncology drugs, is pleased to announce that it has retained the services of MaisonBrison/BarnesMcInerney to develop its investor relations. Services include the development of targeted communication strategies and support in the preparation of meetings with investors.
